Highlights
Australian equities under the ASX 200 umbrella offer a diverse set of options across sectors including travel and healthcare. Bell Potter has recently updated its Australian equities panel, highlighting a pair of companies it views as standout performers in their respective fields.
These selections are based on structural features and internal projections that align with the broker’s outlook on long-term, risk-adjusted returns.
Flight Centre Listed Among Favoured Travel Stocks
Flight Centre Travel Group Ltd (ASX:FLT) has been highlighted for its valuation and post-restructuring business profile. The broker notes that tariff-related headwinds have subsided and the company has shown progress in reducing operational costs.
Additional emphasis has been placed on growth in corporate travel volumes, which is expected to help stabilise earnings through broader economic cycles. The company’s overall cost base adjustments and market positioning in travel distribution have contributed to its inclusion in the panel.
Telix Positioned for Expansion in Radiopharmaceuticals
Telix Pharmaceuticals Ltd (ASX:TLX), a company operating within the medical imaging and therapy space, has also made the broker’s list. The company is working on building a vertically integrated model that spans research, product development, isotope production, and supply chain logistics.
Initial focus remains on the urology segment with multiple offerings across imaging, therapy, and surgical applications. The broker views Telix’s strategy as one aimed at maximising margins by internalising key aspects of the value chain.